Inhibition of DNA synthesis by ionizing radiation: a marker for an S-phase checkpoint

Nicolaas G J Jaspers1, Malgorzata Z Zdzienicka

  • 1Department of Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.

Insights

This study presents a reproducible method to measure radioresistant DNA synthesis (RDS), a key marker for ataxia-telangiectasia (AT). Understanding RDS aids in diagnosing genetic disorders affecting DNA repair and cell cycle control.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cell Biology

Background:

  • Ionizing radiation triggers an S-phase checkpoint inhibiting DNA synthesis.
  • Defects in the S-phase checkpoint are linked to ataxia-telangiectasia (AT), a human inherited disorder.
  • Ataxia-telangiectasia cells exhibit radioresistant DNA synthesis (RDS), a diminished inhibition of DNA synthesis post-irradiation.

Purpose of the Study:

  • To present a simple, accurate, and reproducible experimental protocol.
  • To generate DNA synthesis inhibition curves from cultured cells.
  • To facilitate the study of the S-phase checkpoint and RDS phenotype.

Main Methods:

  • Development of a standardized experimental protocol.
  • Generation of DNA synthesis inhibition curves.
  • Cell culture techniques for assessing DNA synthesis response to genotoxic stress.

Main Results:

  • The presented protocol is simple, accurate, and highly reproducible.
  • Enables reliable measurement of DNA synthesis inhibition.
  • Facilitates the characterization of RDS in various cell types.

Conclusions:

  • The protocol provides a robust tool for studying the S-phase checkpoint.
  • Aids in the diagnosis and understanding of disorders like AT.
  • Contributes to the broader field of DNA damage response research.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...